Based on recent headline ratings, % of this readership currently trusts the local media, which has an average score of % regionally and is currently trending .
Media Trust Score%

Spikevax: EMA recommends approval of adapted COVID–19 vaccine targeting Omicron XBB.1.5

1.5 subvariant. The vaccine — known as Spikevax XBB.1.5 — is to be used for preventing COVID–19 in adults and children from 6 months of age.

  • You already voted!
  • Full Article

    About the Score

    Based on recent headline ratings, % of this readership currently trusts the local media, which has an average score of % regionally and is currently trending .

    Media Trust Score%